The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic reviewKACHROO, Naveen; GNANAPRAGASAM, Vincent J.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 1, pp 1-24, issn 0171-5216, 24 p.Article

May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?BOTTICELLA, Angela; GUARNERI, Alessia; FILIPPI, Andrea Riccardo et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 11, pp 1955-1960, issn 0171-5216, 6 p.Article

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancerHORI, S; JABBAR, T; KACHROO, N et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 2, pp 235-241, issn 0171-5216, 7 p.Article